Pacira Pharmaceuticals (PCRX)

Add to Watchlists
Create an Alert
66.15 -1.57  -2.32% NASDAQ Apr 17, 4:59PM BATS Real time Currency in USD
View Full Chart
PCRX Price Chart
View All Events

PCRX Events

Date Type Description
Feb 25 Misc Pacira Pharmaceuticals, Inc. Q4 2013 Earning Conference Call
Feb 25 Earnings Pacira Pharmaceuticals, Inc. Q4 2013 Earning Result. Estimate: -0.31.
Oct 31 Misc Pacira Pharmaceuticals, Inc. Announces Timing for Third Quarter 2013 Financial Results Webcast and Conference Call
Oct 31 Earnings Pacira Pharmaceuticals, Inc. Announces Timing for Third Quarter 2013 Financial Results. Estimate: -0.37.
Aug 06 Misc Q2 2013 Pacira Pharmaceuticals, Inc. Earnings Conference Call
Aug 06 Earnings Second Quarter 2013 Financial Results. Estimate: -0.43.
May 08 Misc Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call
May 08 Earnings Pacira Pharmaceuticals, Inc. Announces Timing for First Quarter 2013 Financial Results Webcast and Conference Call. Estimate: -0.49.
View All Performance Charts

PCRX Total Returns Comparison

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Pacira Pharmaceuticals is up 124.5% over the last year vs S&P 500 Total Return up 20.96%, Lannett Company up 211.0%, and Actavis up 103.6%.

Get Quote for

PDF Report for PCRX

Download Ratings, Key Stats, Performance Charts, Valuations, and Financials in an easy to print format.

Download PCRX Pro Report PDF
Advertisement

Portfolio Strategies Featuring PCRX

Did Pacira Pharmaceuticals make it into our Portfolio Strategies?
Start your YCharts membership now to find out.

PCRX Profile

  • Sector: Healthcare
  • Industry: Drug Manufacturers - Major
  • Headquarters Country: United States
  • Headquarters State/Province: New Jersey
  • Incorporation Country: United States
  • Incorporation State/Province: Delaware
  • Est. Current Fiscal Quarter End: June 30, 2014
  • Est. Current Fiscal Year End: December 31, 2014
  • Last Fiscal Quarter End: N/A
  • Last Fiscal Year End: N/A
  • NAICS: Pharmaceutical Preparation Manufacturing
  • NAICS Code: 325412
  • NAICS Industry: Pharmaceutical and Medicine Manufacturing
  • NAICS Industry Code: 3254
  • NAICS Sector: Manufacturing
  • NAICS Sector Code: 32

Pacira Pharmaceuticals, Inc. is a specialty pharmaceutical company. The Company is engaged in the development, commercialization and manufacture of proprietary pharmaceutical products for use in hospitals and ambulatory surgery centers.

Recent Quotes

Symbol Price Chg Chg % Market Cap
PCRX 66.15 -1.57 -2.32% 2.230B
Create Watchlist from Quotes
Advertisement

Already registered? Click here to sign in.

Access watchlists and custom data alerts.
Start your free account.

required
required
required
required
required
Get Started Now
document.write('');

{{root.upsell.info.feature_headline}}.
Upgrade to {{root.upsell.info.tier_name}}. Start Your YCharts Membership. Start your {{root.upsell.info.tier_name}} Membership

{{root.upsell.info.feature_description}}

{{root.upsell.info.is_upgrade ? "Upgrade Now" : "Get Started Now"}}

Already a YCharts Member? Already a {{root.upsell.info.tier_name}} Member? Sign in here.